INS and hyperinsulinism: The increase in glucagon secretion and subsequent stimulation of HGO can also stimulate insulin secretion, which could explain the hyperinsulinemia found in patients despite the inhibitory effect of SGAs on GSIS in the initial stages of the treatment.